Neoral dose monitoring using 2-hour cyclosporine post-dose levels in stable children with liver transplants: Improvement in renal function

Pediatric Transplantation

Volumn 7, Issue 6, 2003, Pages 450-453

  Shapiro, Rivka ^a   Waissman, Irit ^a   Mor, Eytan ^b   Kleper, Roxana ^a   Nussinovitch, Moshe ^a   Dinari, Gabriel ^a   Ben Ari, Ziv ^b  

^a S Children's Med Ctr Israel   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

C2 monitoring; Children; Neoral; Renal function

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN; CYCLOSPORIN A; PREDNISONE; TACROLIMUS;

ADOLESCENT; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DRUG ABSORPTION; DRUG CHOICE; DRUG CLEARANCE; DRUG MONITORING; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; HUMAN; KIDNEY FUNCTION; LIVER GRAFT; LIVER TRANSPLANTATION; MAINTENANCE THERAPY; MALE; NEPHROTOXICITY; SCHOOL CHILD;

ADOLESCENT; CHILD; CREATININE; CYCLOSPORINE; DRUG MONITORING; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LIVER TRANSPLANTATION; MALE;

EID: 0345708266     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1397-3142.2003.00087.x     Document Type: Article

References (14)

1. GRANT D, ROCHON J, LEVY G. Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group. Transplant Proc 1996: 28: 2232-2233.
2. ALVAREZ F, ATKINSON PR, GRANT DR, et al. NOF-11: a one year pediatric randomized double-blind comparison of neoral versus Sandimmune in orthotopic liver transplantation. Transplantation 2000: 69: 87-92.
3. KAHAN BD, WELSH M, RUTZKY LP. Challenges in cyclosporine therapy: the role of therapeutic monitoring by area under the curve monitoring. Ther Drug Monitor 1995: 17: 621-624.
4. GRANT D, KNETEMAN N, TCHERVENKOV J, et al. Peak cyclosporine levels (Cmax) correlate with freedom from liver graft rejection. Transplantation 1999: 67: 1133-1137.
5. CANTAROVICH M, BESNER JG, BARKUN JS, ELSTEIN E, LOERTSCHER R. Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy. Clin Transplant 1998: 12: 243-249.
6. CANTAROVICH M, BARKUN JS, TCHERVENKOV JI, BESNER JG, ASPESLET L, METRAKOS P. Comparison of Neoral dose monitoring with cyclosporine trough levels versus 2-hr postdose levels in stable liver transplant patients. Transplantation 1998: 66: 1621-1627.
7. LEVY GA, BURRA P, CAVALLARI A, et al. Improved clinical outcomes for liver transplant recipients using cyclosporine blood level monitoring based on two-hour post-dose levels (C2). Transplantation 2002: 73: 953-959.
8. STROLOGO L, CAMPAGNANO P, FEDERICI G, RIZZONI G. Cyclosporine A monitoring in children: abbreviated area under curve formulas and C2 level. Pediatr Nephrol 1999: 13: 95-97.
9. WANDSTRAT TL, SCHROEDER TJ, MYRE SA. Cyclosporine pharmacokinetics in pediatric transplant recipients. Ther Drug Monitor 1989: 11: 493-496.
10. MCDIARMID SV, ETTENGER RB, HAWKINS RA, et al. The impairment of true glomerular filtration rate in long-term cyclosporine-treated pediatric allograft recipients, Transplantation 1990: 49: 81-85.
11. BARTOSH SM, ALONSO EM, WHITINGTON PF. Renal outcome in pediatric liver transplantation. Clin Transplant 1997: 11: 354-360.
12. CANTAROVICH M, ELSTEIN E, DEVARENNES B, BARKUN J. Clinical benefit of Neoral dose monitoring with cyclosporine 2-hour post dose levels compared to trough levels in stable heart transplant patients. Transplantation 1999: 68: 1839-1842.
13. PORTMAN R, MEDHI N, BRANNAN D, BONILLA M, RUTZKY L, KAHAN B. Abbreviated cyclosporine pharmacokinetics study for management of Neoral dosing in pediatric kidney transplant patients. J Am Soc Nephrol 1996: 7: 1919-1923,
14. SOROF JM, GOLDSTEIN SL, BREWER ED, STEIGER HM, PORTMAN RJ. Serial estimation of glomerular filtration rate in children after renal transplant. Pediatr Nephrol 1999: 13: 737-741.